CD8A and non-small cell lung carcinoma: In a report using RNA sequencing and the CYBERSORT technique to analyze immune cell populations in the blood of patients with NSCLC after the 1st cycle of treatment, fewer CD8+ T cells were found before therapy in patients with durable clinical responses than in patients with progressive disease.